#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Anders Holm Email
COO & Head business development . Zelluna Immunotherapy
How to contact Anders Holm
Join and see Anders's contact info for free!Current Roles
Employees:
33Revenue:
$5.1MAbout
Zelluna Immunotherapy is a company developing transformative T cell receptor (TCR) based cellular immunotherapies for the treatment of solid cancers. The company is developing a unique portfolio of tumor specific TCR's that target the MHC class II pathway to broadly engage the host immune system to provide a safe, efficient and durable clinical response. The company is developing therapies based on the effector functions of autologous T cells (TCR-T) and allogeneic NK cells (TCR-NK). Both of these platforms have their unique advantages and provides the opportunity to attack cancers from multiple angles and improve access to these advanced therapies to a large patient population. For more info please visit www.zelluna.comZelluna Immunotherapy Address
null, null